United Therapeutics
UTHR
#937
Rank
A$36.72 B
Marketcap
A$856.30
Share price
1.49%
Change (1 day)
23.69%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): A$44.69

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is A$43.04. In 2025 the company made an earnings per share (EPS) of A$42.90 an increase over its 2024 EPS that were of A$37.60.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$44.694.18%
2025A$42.9014.1%
2024A$37.6025.59%
2023A$29.9431.54%
2022A$22.7651.18%
2021A$15.05-9.1%
2020A$16.56-581.4%
2019A-$3.44-117.79%
2018A$19.3342.11%
2017A$13.60-40.93%
2016A$23.0313.45%
2015A$20.30104.29%
2014A$9.94100.29%
2013A$4.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.08-97.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.48-1.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A-$2.94-106.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$3.70-108.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
A$10.32-76.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$4.55-89.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
A-$10.26-123.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.90-97.92%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel